Save Ezetimibe as an Add-On in High-Risk Patients

January 2015

Controversy over the role of ezetimibe (Zetia, etc) and the pros and cons of aiming for LDL goals will heat up...again.

Ezetimibe fell out of favor several years ago...when a study showed that adding ezetimibe to simvastatin did NOT work better than simvastatin alone to slow atherosclerosis progression.

Now the big new "IMPROVE-IT" trial shows that adding ezetimibe to simvastatin 40 mg reduces CV events compared to simvastatin alone.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Chronic Illness Document Non-Face-to-Face Care to Get Additional Medicare Payments
Dyslipidemia Save Ezetimibe as an Add-On in High-Risk Patients
Hypothyroidism Explain That Full Benefit of Levothyroxine May Take 6 Months
Antithrombotics Don't Use Newer Oral Anticoagulants for VTEs During Pregnancy
Pediatrics Use Supportive Care Instead of Meds for Bronchiolitis in Kids
Diabetes Use the Shortest and Thinnest Insulin Needle Available
Bipolar Disorder Lean Away From Aripiprazole or Ziprasidone for Bipolar Depression
COPD Choose Between Spiriva Handihaler and Respimat Based on Patient Preference
Eye Health Help Dry-Eye Patients Avoid Topical Vasoconstrictors
Med Administration Recommend a Different Head Position to Make Swallowing Pills Easier
Interactions Think Twice Before Prescribing TMP/SMX With Potassium-Boosting Meds
Generics Write for "Methylphenidate Extended-Release" Instead of Concerta

Save Ezetimibe as an Add-On in High-Risk Patients

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents